Diazadispiroalkane Derivatives Are New Viral Entry Inhibitors
- 18 March 2021
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (4)
- https://doi.org/10.1128/aac.02103-20
Abstract
Herpesviruses are widespread and can cause serious illness. Many currently available antiviral drugs have limited effects, result in rapid development of resistance, and often exhibit dose-dependent toxicity.Funding Information
- Forschungsfoerderung of the Charité (5146115801)
- Sonnenfeld Stiftung
This publication has 36 references indexed in Scilit:
- Inhibition of Human Respiratory Syncytial Virus Infectivity by a Dendrimeric Heparan Sulfate-Binding PeptideAntimicrobial Agents and Chemotherapy, 2012
- A 3- O -Sulfated Heparan Sulfate Binding Peptide Preferentially Targets Herpes Simplex Virus 2-Infected CellsJournal of Virology, 2012
- Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entryVirology, 2010
- Human Cytomegalovirus Glycoprotein B Is Required for Virus Entry and Cell-to-Cell Spread but Not for Virion Attachment, Assembly, or EgressJournal of Virology, 2009
- Inhibition of Transfer to Secondary Receptors by Heparan Sulfate-Binding Drug or Antibody Induces Noninfectious Uptake of Human PapillomavirusJournal of Virology, 2007
- Antiviral drugs for cytomegalovirus diseasesAntiviral Research, 2006
- Human Cytomegalovirus Labeled with Green Fluorescent Protein for Live Analysis of Intracellular Particle MovementsJournal of Virology, 2005
- Human Cytomegalovirus Resistance to Antiviral DrugsAntimicrobial Agents and Chemotherapy, 2005
- Herpes simplex virus: receptors and ligands for cell entryCellular Microbiology, 2004
- Further Evidence that Papillomavirus Capsids Exist inTwo DistinctConformationsJournal of Virology, 2003